Next Article in Journal
Broad-Spectrum Antibiotic Use and Disease Progression in Early-Stage Melanoma Patients: A Retrospective Cohort Study
Next Article in Special Issue
Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas
Previous Article in Journal
miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma
Previous Article in Special Issue
FDG-PET/CT for the Management of Post-Chemotherapy Residual Mass in Hodgkin lymphoma

Hodgkin Lymphoma in People Living with HIV

Department of Hematology, Institute Català d’Oncologia-Germans Trias i Pujol Hospital, Carretera de Canyet s/n, 08916 Barcelona, Spain
Josep Carreras Leukaemia Research Institute, 08916 Badalona, Spain
Departament de Medicina, Can Ruti Campus, Unitat Docent Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain
Fundació Lluita Contra la Sida, Infectious Diseases Department, Germans Trias i Pujol Hospital, 08916 Badalona, Spain
Department of Pathology, Germans Trias i Pujol Hospital, 08916 Badalona, Spain
Author to whom correspondence should be addressed.
Academic Editor: David Wong
Cancers 2021, 13(17), 4366;
Received: 31 July 2021 / Revised: 20 August 2021 / Accepted: 25 August 2021 / Published: 29 August 2021
(This article belongs to the Special Issue Hodgkin Lymphoma)
Hodgkin lymphoma (HL) is a non-AIDS defining neoplasm, but people living with HIV (PLWH) have between a 5- and 26-fold higher risk of developing it than the general population. Epstein-Barr virus is present in almost all HIV-related HL cases, and plays an important role in its etiopathogenesis. Despite the aggressive characteristics, the prognosis of HL affecting PLWH is similar to that of the general population if patients are treated following the same recommendations. Administration of cART concomitantly with chemotherapy is highly recommended. However, this combination may be challenging due to drug–drug interactions and overlapping toxicity. Thus, interdisciplinary collaboration between hemato-oncologists and HIV specialists is crucial for the optimal treatment of both lymphoma and HIV infection.
Despite widespread use of combined antiretroviral therapy (cART) and increased life expectancy in people living with HIV (PLWH), HIV-related lymphomas (HRL) remain a leading cause of cancer morbidity and mortality for PLWH, even in patients optimally treated with cART. While the incidence of aggressive forms of non-Hodgkin lymphoma decreased after the advent of cART, incidence of Hodgkin lymphoma (HL) has increased among PLWH in recent decades. The coinfection of Epstein–Barr virus plays a crucial role in the pathogenesis of HL in the HIV setting. Currently, PLWH with HRL, including HL, are treated similarly to HIV-negative patients and, importantly, the prognosis of HL in PLWH is approaching that of the general population. In this regard, effective cART during chemotherapy is strongly recommended since it has been shown to improve survival rates in all lymphoma subtypes, including HL. As a consequence, interdisciplinary collaboration between HIV specialists and hemato-oncologists for the management of potential drug–drug interactions and overlapping toxicities between antiretroviral and antineoplastic drugs is crucial for the optimal treatment of PLWH with HL. In this article the authors review and update the epidemiological, clinical and biological aspects of HL presenting in PLWH with special emphasis on advances in prognosis and the factors that have contributed to it. View Full-Text
Keywords: HIV; hodgkin lymphoma; antiretroviral therapy; prognosis HIV; hodgkin lymphoma; antiretroviral therapy; prognosis
Show Figures

Figure 1

MDPI and ACS Style

Navarro, J.-T.; Moltó, J.; Tapia, G.; Ribera, J.-M. Hodgkin Lymphoma in People Living with HIV. Cancers 2021, 13, 4366.

AMA Style

Navarro J-T, Moltó J, Tapia G, Ribera J-M. Hodgkin Lymphoma in People Living with HIV. Cancers. 2021; 13(17):4366.

Chicago/Turabian Style

Navarro, Jose-Tomas, José Moltó, Gustavo Tapia, and Josep-Maria Ribera. 2021. "Hodgkin Lymphoma in People Living with HIV" Cancers 13, no. 17: 4366.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop